{"name": "MabVax Therapeutics",
 "permalink": "mabvax-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/mabvax-therapeutics",
 "homepage_url": "http://www.mabvax.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "858-259-9405",
 "description": "",
 "created_at": "Wed Nov 21 03:28:11 UTC 2012",
 "updated_at": "Tue Jan 22 12:38:04 UTC 2013",
 "overview": "\u003Cp\u003EMabVax is a clinical stage biopharmaceutical company focused on the commercialization of proprietary anti-cancer immunotherapies resulting from two integrated and successful technology platforms. The first is a series of vaccines developed at Memorial Sloan-Kettering Cancer Center (MSKCC) and licensed to MabVax. Two of the company\u2019s lead cancer vaccines are currently undergoing proof of concept Phase II multi-center clinical trials for the treatment of soft tissue sarcoma and ovarian cancer. Both trials have received $2MM or more in federal grant monies. The second is a human antibody discovery platform developed internally and based on the protective immune responses generated from patients who have been successfully immunized against targeted cancers with the licensed vaccines. The company\u2019s lead human antibody candidate is undergoing preclinical evaluation for development against colon, pancreatic and breast cancers and has received $1.1MM in federal grant monies. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       41],
      "assets/images/resized/0022/1358/221358v2-max-150x150.jpg"],
     [[250,
       69],
      "assets/images/resized/0022/1358/221358v2-max-250x250.jpg"],
     [[289,
       80],
      "assets/images/resized/0022/1358/221358v2-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President and CEO",
    "person":
     {"first_name": "David",
      "last_name": "Hansen",
      "permalink": "david-hansen",
      "image": null}},
   {"is_past": false,
    "title": "Chief Science Officer",
    "person":
     {"first_name": "Philip",
      "last_name": "Livingston",
      "permalink": "philip-livingston",
      "image": null}},
   {"is_past": false,
    "title": "Vice President of Vaccine Technology",
    "person":
     {"first_name": "Govind",
      "last_name": "Ragupathi",
      "permalink": "govind-ragupathi",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$5.25M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://www.finsmes.com/2012/11/mabvax-therapeutics-closes-5-25m-series-financing.html",
    "source_description": "MabVax Therapeutics Closes $5.25M in Series B Financing",
    "raised_amount": 5250000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 11,
    "funded_day": 20,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Numoda Capital Innovations",
         "permalink": "numoda-capital-innovations",
         "image":
          {"available_sizes":
            [[[150,
               97],
              "assets/images/resized/0022/1362/221362v1-max-150x150.jpg"],
             [[165,
               107],
              "assets/images/resized/0022/1362/221362v1-max-250x250.jpg"],
             [[165,
               107],
              "assets/images/resized/0022/1362/221362v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Burrill \u0026 Company",
         "permalink": "burrill-co",
         "image":
          {"available_sizes":
            [[[150,
               25],
              "assets/images/resized/0005/0402/50402v1-max-150x150.png"],
             [[250,
               43],
              "assets/images/resized/0005/0402/50402v1-max-250x250.png"],
             [[250,
               43],
              "assets/images/resized/0005/0402/50402v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "11588 Sorrento Valley Road, Suite 20",
    "address2": "",
    "zip_code": "92121",
    "city": "San Diego",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        125],
       "assets/images/resized/0022/1359/221359v1-max-150x150.jpg"],
      [[250,
        209],
       "assets/images/resized/0022/1359/221359v1-max-250x250.jpg"],
      [[450,
        377],
       "assets/images/resized/0022/1359/221359v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}